BioSpace News Archive

Comar, a leading designer and manufacturer of quality healthcare packaging products, introduces the new SecureCap® QuarterLoc™ child resistant closure, a one-piece push-and-turn bottle closure that requires only a quarter turn to apply or remove.

Actinium Pharmaceuticals, Inc., (NYSE AMERICAN: ATNM) today announced that it will present at 2018 B. Riley FBR Healthcare Conference on Tuesday, September 4th and at the Maxim Rights Offering Conference on Thursday, September 6th, both of which are being held in New York City.

The WIRB-Copernicus Group®'s (WCG™) Clinical Services Division has partnered with Inspire, the largest online community of patients and caregivers, to make clinical research more accessible to all patients, especially those suffering from rare and genetic-based diseases.

oshiba Global Commerce Solutions, a global market share leader for integrated in-store retail solutions, announced continued growth in their partnership with CVS Pharmacy to provide the leading pharmacy retailer with a digital commerce platform to accelerate deployment of new capabilities and in-store experiences.

Baxter International, Inc. (NYSE:BAX), a global leader in clinical nutrition, is showcasing OLIMEL 7.6%, the latest addition to the company’s olive oil-based parenteral nutrition portfolio, at the 40th Congress of the European Society of Clinical Nutrition and Metabolism (ESPEN), taking place from September 1 to 4.

Puma Biotechnology, Inc. announced that the European Commission, has granted marketing authorization for NERLYNX for the extended adjuvant treatment of adult patients with early stage hormone receptor positive HER2-overexpressed/amplified breast cancer

Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, and OS Therapies LLC, a clinical-stage therapeutic company focused on the identification, development and commercialization of treatments for osteosarcoma, today announced that Advaxis has granted a license to OS Therapies for the use of ADXS31-164, also known as ADXS-HER2, for evaluation in the treatment of osteosarcoma in humans.

Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, announced today that Pat Ryan has been appointed Chief Operating Officer,

In its continuing commitment to improve access to affordable health care for all Americans, CVS Health [NYSE: CVS] is kicking off its annual Project Health campaign at CVS Pharmacy locations in the greater Chicago area this Thursday, September 6, with free health and wellness screenings

In its continuing commitment to improve access to affordable health care for all Americans, CVS Health [NYSE: CVS] is expanding its annual Project Health campaign to include locations across Rhode Island.